NextFin News - OpenAI's initial public offering will not happen until 2027, Chief Executive Sam Altman said in an interview published September 12, 2026, a sharp reversal from the company's confidential S-1 filing in June and its ambition to command a $1 trillion public valuation. The reason is not money, markets, or demand: it is the risk that the machines themselves could escape human control.
Altman said an IPO now would be "ill-timed" given the safety concerns surrounding frontier artificial intelligence, and that safety standards are "not at a place" to push AI capabilities much further. He described the prospect of AI beyond human control as "absolutely" possible, and said he would have no problem standing up to investors if he needed to pause or stop development altogether.
The statement reframes one of the most anticipated capital-markets events of the decade. OpenAI had hired bankers and lawyers with an eye toward a listing as soon as the third or fourth quarter of 2026, and had pushed advisers to find a path to a $1 trillion valuation — up from a $730 billion private mark before its March funding round. That round closed at an $852 billion post-money valuation on $122 billion of committed capital, the largest private raise in history. A delay to 2027 means the company must keep burning cash, keep funding a GPU buildout measured in gigawatts, and keep betting that safety research can catch up to model capability — all while remaining private.
The immediate market read was unforgiving. Nvidia, the clearest public proxy for AI infrastructure spending, slipped roughly 1.5% as traders digested the news, while Advanced Micro Devices, Broadcom, and other semiconductor names fell further. The move capped a rough stretch for chips: the Nasdaq Composite logged its worst day in more than a year earlier in September as the AI trade wobbled. A delayed OpenAI IPO does not cancel any signed supply contract, but it does remove the moment when private-market euphoria would have been tested against public-market discipline.
What Changed: From a June Filing to a 2027 Wait
The timeline tells the story of a company that prepared to go public and then pulled back. On June 8, 2026, OpenAI confidentially filed its S-1 registration statement with the Securities and Exchange Commission, a procedural step that lets a company gauge investor demand before revealing its finances. By late June, people involved in the deliberations said the company was leaning toward waiting until 2027, after advisers cautioned that retail investors might not embrace the shares amid choppy global markets and questions about whether AI companies can live up to their promises.
Two forces were already at work before the safety framing took over. First, the valuation math had become unforgiving. At an $852 billion post-money valuation against an annualized revenue run rate of roughly $25 billion, OpenAI was pricing in a price-to-sales multiple near 34 — far above the roughly 25 times sales at which Nvidia traded, and in a range where only a handful of S&P 500 names, such as Palantir at more than 100 times sales, stood higher. Second, the cash burn was accelerating. Under a renegotiated Microsoft partnership announced in April 2026, OpenAI's revenue-share payments to Microsoft are capped at $38 billion through 2030, down approximately $97 billion from the prior projected path, but the revised terms pull roughly $6 billion of payments into this year and push projected cash burn to about $27 billion in 2026 and $63 billion in 2027.
Then came the safety shock. On September 9, an Anthropic researcher resigned publicly, warning that all of humanity could be destroyed by AI and that major frontier labs were "gambling with our lives." The incident lifted the probability of doom — "(p)doom," in the industry's shorthand — into the open. Elon Musk's (p)doom estimate has hovered between 10% and 20%; Anthropic Chief Executive Dario Amodei's runs 10% to 25%. In that atmosphere, Altman's decision to tie the IPO delay to safety rather than to valuation is a strategic choice: it makes the delay a governance stance, not a market concession.
"No gamble with humanity is OK," Altman said in the interview, adding that he would have no problem standing up his investors if he needed to pause or stop AI development altogether. He also alluded to a pact he is making with industry peers to slow down while safety and alignment solutions catch up to model capabilities.
The safety rationale also serves a second purpose. An S-1 is a disclosure document: it forces a company to lay out its risks, including existential ones, in language that retail investors, regulators, and plaintiffs' lawyers will all read. By moving the IPO to 2027, OpenAI buys time to let safety standards mature, to let the industry-wide pact take shape, and to let its financial profile improve enough that a $1 trillion debut looks defensible rather than desperate.
The Mechanism: Why a Delayed IPO Changes the Cost of Capital
The obvious reading of a delayed IPO is that it is a scheduling change. The second-order reading is that it changes the entire cost and structure of the capital that funds the AI buildout.
While private, OpenAI can raise money at valuations set by a small group of sophisticated investors willing to underwrite existential risk for frontier exposure. The March round proved the point: $122 billion of committed capital at an $852 billion post-money valuation, anchored by Amazon, Nvidia, and SoftBank, with continued participation from Microsoft and a long roster of global institutions. That is a negotiated price, not a market price.
A public listing would replace negotiated pricing with continuous pricing. Public shareholders price in quarterly earnings, not five-year optionality. They react to guidance misses within minutes. They vote with their shares when a CEO says he might pause development. For a company projecting $63 billion of cash burn in 2027 and breakeven no earlier than 2029 or 2030, the public market is a harsher funder than the private one. The delay keeps OpenAI in the more forgiving private regime for another year.
There is also a control mechanism at work. Altman has said he is "0%" excited about being the chief executive of a public company, and that while he is excited for OpenAI to be public "in some ways," he thinks "it'd be really annoying" in others — remarks made in a podcast interview in December 2025. Public-company status dilutes founder control and increases regulatory scrutiny. A 2027 IPO, if it happens at all, is more likely to come with a dual-class share structure or other control-preserving features — the kind of arrangement public-market stewards have grown skeptical of after years of founder-led governance disputes.
The supply-chain channel runs the other way. OpenAI's compute plans are already locked in: a 10-gigawatt data-center deployment with Nvidia systems announced in September 2026, alongside a reported $100 billion investment commitment from Nvidia; a $300 billion five-year Oracle cloud deal announced in September 2025 that begins delivering capacity in 2027; and the renegotiated Microsoft arrangement that shifts cash flow but does not reduce total compute demand. A delayed IPO does not unwind those contracts. What it changes is the sequencing of equity validation: the suppliers get paid either way, but the equity story that justified the spending does not get tested until 2027.
The Counter-Thesis: Safety Is the Cover, Not the Cause
The strongest argument against the safety-first reading is the simpler one: the delay is about valuation and cash, not existential risk. OpenAI's advisers pushed Altman to move slowly after SpaceX's stock proved volatile in its public debut, and after the start-up's financial challenges became harder to ignore. A company burning $27 billion in 2026 and $63 billion in 2027, at an $852 billion valuation and roughly 34 times sales, faces a narrow path to a successful $1 trillion IPO. In that telling, "safety" is the publicly palatable explanation for a decision that was really about avoiding a down round or a weak debut.
This counter-thesis has real support. The confidential S-1 was filed in June, when market conditions were already deteriorating. Advisers explicitly cautioned that retail investors might not embrace the shares. And the SpaceX comparison is telling: a sister company with a similar founder, a similar valuation narrative, and a public debut that turned volatile quickly. Advisers steering a client away from that outcome are doing their job.
But the counter-thesis does not fully explain the timing or the framing. If the decision were purely financial, Altman could have cited market conditions — as the advisers did in June — rather than tying the delay to safety standards and a peer pact. The September 9 Anthropic resignation created a new political and regulatory reality: lawmakers who had spent years largely sidestepping AI safety suddenly found a concrete, human signal to act on. In that environment, an IPO framed around existential risk would invite congressional hearings, SEC scrutiny of risk disclosures, and a public debate over whether a company that admits its technology could destroy humanity is fit to sell shares to retail investors. The safety rationale is not merely a cover; it is the binding constraint that made a 2026 listing politically impossible even if the valuation had been achievable.
Both forces are present, and they point in the same direction: delay. The financial leg is cyclical — markets recover, multiples re-rate, burn ratios improve. The safety leg is structural — it is about the durability of the technology itself and the governance regime that will surround it. A cyclical wave and a structural shift are both pushing the IPO into 2027.
What to Watch: The Signals That Decide 2027
The base case is that OpenAI lists in 2027, at or above the $1 trillion level Altman sought, assuming revenue growth holds, burn narrows toward guidance, and the safety pact produces visible milestones. The upside case is an earlier listing in late 2026 if safety disclosures satisfy regulators and private-market demand stays strong — Forge Global's derived private-share price sat near $721.85 per share, implying roughly an $894 billion valuation as of September 10, 2026, already above the March round. The downside case is a 2028-or-later listing, or a materially lower valuation, if burn accelerates beyond $63 billion, if the safety pact fractures, or if a severe AI incident forces a development pause.
Three signals would falsify the 2027 base case. First, if OpenAI's annualized revenue run rate exceeds $40 billion by mid-2027 while cash burn stays below $30 billion, the financial argument for waiting evaporates and an earlier listing becomes likely. Second, if core PCE inflation stays below 2% and the Federal Reserve cuts rates aggressively, public-market appetite for long-duration, pre-profitability growth would return faster than expected, pulling the IPO forward. Third, and most important, if the industry safety pact produces binding, verifiable slowdown commitments from Anthropic, Google DeepMind, and xAI within six months, the safety rationale weakens because the collective-action problem it was meant to solve has been addressed.
For investors, the asymmetry is clear. Nvidia, Microsoft, Amazon, and Oracle are the exposed suppliers and partners: their revenue depends on OpenAI's continued spending, not on its listing date, so a delay is a timing issue, not a thesis issue. Anthropic is the competitive beneficiary of a slower peer: with a $350 billion valuation, a law firm already selected for IPO work, and a possible 2026 listing, it can capture talent, enterprise contracts, and investor attention while OpenAI remains private. Retail investors, meanwhile, remain locked out of the world's most valuable private AI company — which is exactly the outcome a safety-first delay was designed to produce.
The central judgment: OpenAI's IPO delay is a market-timing decision dressed in safety language, but the safety language is what makes it binding. A company that says its technology could escape human control cannot credibly ask retail investors to fund it at a $1 trillion valuation in the same year. The delay is not a retreat from the public markets; it is a recognition that the public markets are not yet ready to price existential risk.
Data as of September 12, 2026. Market figures reflect intraday trading on the day of the announcement.
Explore more exclusive insights at nextfin.ai.
